Fenofibrate Monograph: PPAR-Alpha, Triglycerides, Kidney Dosing and Safety
Evidence-informed medical pharmacology article updated 10 November 2026. For education; prescribing requires current local labeling and individual patient assessment. Overview Fenofibrate is a fibrate lipid-modifying medicine used principally to lower elevated triglycerides. Its triglyceride-lowering effect does not mean it reliably adds cardiovascular event reduction when prescribed to every statin-treated patient. Treat secondary causes, dietary factors,…